Morgan Stanley Call 9000 PX1 21.0.../ DE000MB816C9 /
04/06/2024 10:14:51 | Var.0.000 | Denaro04/06/2024 | Lettera04/06/2024 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
0.015EUR | 0.00% | 0.015 Quantità in denaro: 100,000 |
0.040 Quantità in lettera: 100,000 |
CAC 40 | 9,000.00 - | 21/06/2024 | Call |
GlobeNewswire
13:52
Pairwise Develops First Seedless Blackberry with Transformative CRISPR Technology
GlobeNewswire
13:30
DeFi Technologies Subsidiary Valour Inc. Expands Collaboration with justTRADE; 1Valour STOXX Bitcoin...
GlobeNewswire
13:30
BridgeBio Announces Durable Month 12 and 18 Phase 2 Cohort 5 Results of Oral Infigratinib in Achondr...
Newsfile Corp
13:21
HKSTP Showcases Top Biotech Innovations and Attracts Global Enterprises at US BIO 2024
Newsfile Corp
13:18
KEMO SAAS Launches All-In-One Marketing & Sales Platform to Transform Business Workflows
Newsfile Corp
13:00
Blue Thunder Mining Inc. change de nom pour devenir Mines D'or Orbec, et installe son siège social à...
GlobeNewswire
13:00
Annexon Announces Positive Topline Results from Pivotal Phase 3 Trial for First-in-Class C1q Blockin...
GlobeNewswire
13:00
Mobilicom CEO Oren Elkayam to Advocate for Uncrewed Systems at AUVSI's Hill Day in Washington, D.C.
GlobeNewswire
13:00
23andMe and the Colorectal Cancer Alliance Collaborate to Help Advance Colorectal Cancer Research in...
GlobeNewswire
13:00
Amicus Therapeutics Receives Prix Galien U.K. Award for Pombiliti® (cipaglucosidase alfa) + Opfolda®...
GlobeNewswire
13:00
ConnectWise Introduces Sidekick for Security: Transforming Cyber Defense with AI